Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the treatment of type 2 diabetes mellitus and, more recently, obesity
Semaglutide MechanismGLP-1 receptor agonist DosingWeekly Personalized by your provider Same priceEvery dose, every titration Best forFirst-time GLP-1 users longer track record Price$175 / month or $449 for 3 months upfront Tirzepatide MechanismGLP-1 + GIP receptor agonist DosingWeekly Personalized by your provider Same priceEvery dose, every titration Best forPatients seeking dual-mechanism support Price$215 / month or $549 for 3 months upfront Real results from real people
Diabetes, Obesity & Metabolism, 24 (9), 18611868
Shohei Yamada, Jun Tanabe, Yuji Ogura, Yoshio Nagai, Takeshi Sugaya, Keiichi Ohata, Yasunori Natsuki, Daisuke Ichikawa, Shiika Watanabe, Kazuho Inoue, Seiko Hoshino, Kenjiro Kimura, Yugo Shibagaki, Atsuko Kamijo-Ikemori
GLP-1 addresses appetite biology, not the psychiatric and behavioral roots of BED